Preparations for COVID-19 vaccinations now in progress RIVM is preparing for implementation of the coronavirus vaccinations. As soon as there is a safe and effective vaccine against the novel coronavirus, it will be quickly and carefully deployed to vaccinate the target groups.
R number rises to 1, decrease in newly reported COVID-19 infections slows In the past week, the Municipal Health Services (GGDs) reported 36,931 new reports of confirmed COVID infections. This is about the same as in the previous week, when 37,706 new COVID-19 infections were reported (-2%).
Second wave is subsiding far slower than the first wave For the second week in a row, the number of newly reported COVID-19 infections decreased last week compared to the week before that.
Decrease in COVID-19 cases as expected, high number of contagious people persists The number of newly reported COVID-19 infections decreased last week compared to the week before that. The number of newly reported infections is dropping in all regions.
Coronavirus monitoring in sewage now easier to compare on Coronavirus Dashboard Starting this week, the measurement results from the sewage research in various municipalities and security regions can be compared on the Coronavirus Dashboard.
Slight decrease in newly reported COVID-19 infections, R still above 1 The number of newly reported COVID-19 infections decreased slightly last week compared to the week before that. Reproduction number R is still entirely above 1.
EFSA agrees with RIVM that potential effect of BPA on the immune system requires further attention RIVM expressed concerns on the effects of bisphenol a (BPA) on the immune system in a report issued in March 2016.
RIVM provides overview of the possible risks of bisphenol A RIVM has created an overview of the possible risks of Bisphenol A (BPA) for humans and the environment. BPA is a component of many different products and affects the endocrine system.